EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis

Lukas A Heger iD, Nicolas Schommer iD, Shoichi Fukui, Stijn Van Bruggen iD, Casey E Sheehy, Long Chu iD, Sridharan Rajagopal, Dhanalakshmi Sivanandhan, Bruce Ewenstein, Denisa D Wagner iD

Life Science Alliance · 2023-10 · 6 (10) · e202302055

DOI: 10.26508/lsa.202302055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 27.07.2023. Verfasst von Lukas A Heger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Heart Failure, Arthritis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis is a prototypic inflammatory condition with affected patients being at greater risk of incident heart failure (HF). Targeting innate immune cell function in the pathogenesis of HF bears the potential to guide the development of future therapies. A collagen-induced arthritis (CIA) model in DBA/1 J mice was used to generate arthritis. Mice with CIA developed concentric hypertrophic myocardial remodeling, left ventricular (LV) diastolic dysfunction, and HF with elevated plasma B-type natriuretic peptide levels but preserved LV ejection fraction. Key features of HF in CIA were increased infiltration of activated neutrophils, deposition of neutrophil extracellular traps in the myocardium, and increased tissue levels of the proinflammatory cytokine IL-1β. Specific inhibition of protein arginine deiminase 4 (PAD4) by an orally available inhibitor (JBI-589), administered after the onset of clinical arthritis, prevented HF with reduced neutrophil infiltration. We identify PAD4-mediated neutrophil activation and recruitment as the key thromboinflammatory pathway driving HF development in arthritis. Targeting PAD4 may be a viable therapeutic approach for the prevention of HF secondary to chronic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureArthritisMiceAnimalsProtein-Arginine Deiminase Type 4Mice, Inbred DBAInflammation

Substanzen

Protein-Arginine Deiminase Type 4

Autor:innen und Institutionen

  • Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Departement of Cardiology and Angiology, University Hospital Freiburg Bad Krozingen, Freiburg, Germany.
  • Center of Molecular and Vascular Biology, Department of Cardiovascular Science, KU Leuven, Leuven, Belgium.
  • Jubilant Therapeutics Inc., Bedminster, NJ, USA.
  • Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA denisa.wagner@childrens.harvard.edu.

ORCID-Profile: Lukas A Heger, Nicolas Schommer, Stijn Van Bruggen, Long Chu, Denisa D Wagner

Förderung

  • NHLBI NIH HHS
  • HHS | NIH | National Heart, Lung, and Blood Institute
  • Deutsche Forschungsgemeinschaft
  • German Research Foundation
  • Society for Thrombosis and Haemostasis Research e.V.

Zitieren

APA

Heger, L. A., Schommer, N., Fukui, S., Van Bruggen, S., Sheehy, C. E., Chu, L., Rajagopal, S., Sivanandhan, D., Ewenstein, B., & Wagner, D. D. (2023). Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis. Life Science Alliance, 6(10), e202302055. https://doi.org/10.26508/lsa.202302055

Vancouver

Heger LA, Schommer N, Fukui S, Van Bruggen S, Sheehy CE, Chu L, et al. Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis. Life Science Alliance. 2023;6(10):e202302055. doi:10.26508/lsa.202302055

BibTeX
@article{Heger2023,
  author = {Heger, Lukas A and Schommer, Nicolas and Fukui, Shoichi and Van Bruggen, Stijn and Sheehy, Casey E and Chu, Long and Rajagopal, Sridharan and Sivanandhan, Dhanalakshmi and Ewenstein, Bruce and Wagner, Denisa D},
  title = {Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis},
  journal = {Life Science Alliance},
  year = {2023},
  volume = {6},
  number = {10},
  pages = {e202302055},
  doi = {10.26508/lsa.202302055}
}
Kostenlos starten →